Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Raw Materials (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Raw Materials over the past 7 years, most recently at $14.6 million for Q4 2018.

  • For Q4 2018, Raw Materials rose 10.42% year-over-year to $14.6 million; the TTM value through Nov 2018 reached $14.6 million, up 10.42%, while the annual FY2018 figure was $15.3 million, 50.48% up from the prior year.
  • Raw Materials for Q4 2018 was $14.6 million at Lifecore Biomedical, Inc. \De\, up from $13.9 million in the prior quarter.
  • Over five years, Raw Materials peaked at $15.3 million in Q2 2018 and troughed at $4.2 million in Q4 2016.
  • A 5-year average of $11.2 million and a median of $10.9 million in 2014 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: crashed 62.27% in 2016 and later surged 215.73% in 2017.
  • Year by year, Raw Materials stood at $12.1 million in 2014, then dropped by 8.15% to $11.1 million in 2015, then crashed by 62.27% to $4.2 million in 2016, then surged by 215.73% to $13.2 million in 2017, then increased by 10.42% to $14.6 million in 2018.
  • Business Quant data shows Raw Materials for LFCR at $14.6 million in Q4 2018, $13.9 million in Q3 2018, and $15.3 million in Q2 2018.